Mannin Research Inc. is a Canadian biotechnology company with a subsidiary in Germany, Mannin GmbH. Our team is focused on the discovery, research, development and commercialization of therapeutics for vascular diseases using a novel mechanism of action targeting the Tie2 (TEK) receptor tyrosine kinase. Mannin has a diverse pipeline of novel therapeutics to treat a variety of vascular-related diseases.

Mannin Research Inc. Logo



Event details

Date: June 13 - 16, 2022

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


26 in total